Archive

New ketamine study promises extended relief for depression

Written by Charlie King | 4 Jun 2025

Roughly 10 percent of the U.S. population is afflicted with major depressive disorder at any given time, and up to 20 percent will exhibit MDD symptoms over their lifetimes. Yet… read more.

Greater patient education needed around antidepressants which may reduce genital sensitivity, SFU study finds

Written by Charlie King | 10 Dec 2024

The use of antidepressants is associated with sexual side effects including reduced genital sensitivity that persists after stopping the medication, a new Simon Fraser University study finds. The… read more.

Artificial intelligence helps predict whether antidepressants will work in patients

Written by Charlie King | 8 Feb 2024

In patients with major depression disorder it is, thanks to use of artificial intelligence, now possible to predict within a week whether an antidepressant will work. With the… read more.

2 common types of antidepressants were safe for most stroke survivors

Written by Charlie King | 1 Feb 2024

Most stroke survivors were able to safely take two types of common antidepressants, according to a preliminary study to be presented at the American Stroke Association’s International Stroke Conference… read more.

Esketamine shows higher efficacy than quetiapine in treatment-resistant depression

Written by Bruce Sylvester | 19 Oct 2023

Researchers report that patients treated for treatment-resistant depression with esketamine NS (nasal spray), a form of ketamine, achieve better and more durable outcomes than similar patients treated with… read more.

People living with HIV at substantially higher risk of depression and suicide, especially in first 2 years after diagnosis

Written by Charlie King | 9 Apr 2023

People living with HIV (PLWH) are far more likely to be diagnosed with depression, take antidepressants, be treated with electroconvulsive therapy, and commit suicide than population controls, especially… read more.

Scientists explain emotional ‘blunting’ caused by common antidepressants

Written by Charlie King | 24 Jan 2023

Scientists have worked out why common anti-depressants cause around a half of users to feel emotionally ‘blunted’. In a study published today, they show that the drugs affect… read more.

Vitamin D supplementation seems to alleviate depressive symptoms in adults

Written by Charlie King | 15 Aug 2022

An extensive meta-analysis suggests that vitamin D supplementation may alleviate depressive symptoms in adults with depression. Conducted by an international team of researchers, the meta-analysis includes dozens of… read more.

Low addiction risk with medical use of ketamine

Written by Charlie King | 6 Aug 2022

Commonly used in medicine as an anaesthetic, ketamine is also increasingly prescribed to relieve depressive symptoms. This very fast-acting psychotropic drug is particularly indicated for the treatment of… read more.

Psychotherapy found to be ineffective or unavailable for medicated patients with severe depression

Written by Charlie King | 8 Jun 2022

Antidepressants are the first-choice treatment for severe depression. Antidepressant use is often supplemented by psychotherapy. Now a major ongoing international study has shown that adding psychotherapy treatment to… read more.

Antidepressants may improve outcomes in persons with diabetes and depression

Written by Bruce Sylvester | 2 Aug 2021

Researchers report that patients diagnosed with both diabetes and depression who are treated with antidepressants appear to achieve a lower risk of death and of serious diabetes complications…. read more.

How do antidepressants trigger fear and anxiety?

Written by Charlie King | 4 May 2021

More than 100 million people worldwide take selective serotonin reuptake inhibitors (SSRIs), such as Prozac and Zoloft, to treat depression, anxiety and related conditions, but these drugs have… read more.

Archive

Subscribe for our mailing list

Follow Us